CTGov Compliance My Organizations - CTGov Compliance

user1
|
Logout

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 4 of 4 entries

View as:

A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal

NCT ID: NCT02279563 Org: User:

Start: 12/31/13 End: - Due: -

A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal

NCT ID: NCT00987233 Org: User:

Start: - End: - Due: -

A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal

NCT ID: NCT02273817 Org: User:

Start: 03/31/11 End: 08/31/11 Due: 08/31/12

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

Phase: N/A Priority: Normal

NCT ID: NCT00859105 Org: User:

Start: 02/29/08 End: - Due: -

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis	NCT02279563	Apotex Inc.	user2@example.com	None	2013-12-31	-	-	-	-	2025-07-14
A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis	NCT00987233	Apotex Inc.	user2@example.com	None	-	-	-	-	-	2025-07-14
A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis	NCT02273817	Apotex Inc.	user2@example.com	None	2011-03-31	2011-08-31	2012-08-31	-	-	2025-07-14
A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis	NCT00859105	Apotex Inc.	user2@example.com	None	2008-02-29	-	-	-	-	2025-07-14